.Novartis levels a new outpost in its own cooperation with Voyager Rehabs, spending $15 million to o...
.On the heels of an FDA denial for its own main rival Novo Nordisk, Eli Lilly is gaining ground in t...
.Only a handful of months after dosing the first individual in a phase 2 trial for recently diagnose...
.Eli Lilly's search for excessive weight intendeds has led it to the black genome. The Big Pharma ha...
.Toolbox Biosciences is actually going on up. The tissue treatment company has added on $325 million...
.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has submitted...
.Aelis Farma's hopes of getting a fast, good decision on a $one hundred thousand alternative remitta...
.ProKidney has ceased among a pair of phase 3 tests for its cell therapy for kidney disease after ch...
.Vaxcyte revealed what analysts called "magnificent" period 1/2 information for its 31-valent pneumo...
.Recursion has stumbled via an early examination of its tech-enabled strategy to medicine revelation...